Igarashi, R., Inoue, T., Fujiyama, N., Tsuchiya, N., Numakura, K., Kagaya, H., Saito, M., Narita, S., Satoh, S., Niioka, T., Miura, M., Habuchi, T. (2018) Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma. Med Oncol., 35(4), 51.
Inoue, T., Miyazaki, J., Ichioka, D., Narita, S., Kageyama, S., Sugimoto, M., Mitsuzuka, K., Shiraishi, Y., Kinoshita, H., Wakeda, H., Nomot,o T., Kikuchi, E., Matsui, Y., Fujie, K., Habuchi, T., Nishiyama, H. (2018) A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional study. BMC Cancer., 18(1), 290.
Kagaya, H., Niioka, T., Saito, M., Inoue, T., Numakura, K., Yamamoto, R., Akamine, Y., Habuchi, T., Satoh, S., Miura, M. (2018) Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients. Int J Mol Sci., 19(3), E882.
Koizumi, A., Narita, S., Nara, T., Takayama, K., Kanda, S., Numakura, K., Tsuruta, H., Maeno, A., Huang, M., Saito, M., Inoue, T., Tsuchiya, N., Satoh, S., Nanjo, H., Habuchi, T. (2018) Incidence and location of positive surgical margin among open, laparoscopic and robot-assisted radical prostatectomy in prostate cancer patients: a single institutional analysis. Jpn J Clin Oncol., 48(8), 765-770.
Komine, N., Satoh, S., Saito, M., Numakura, K., Inoue, T., Tsuruta, H., Narita, S., Komatsuda, A., Nanjo, H., Kagaya, H., Niioka, T., Miura, M., Mitobe, Y., Habuchi, T. (2018) Influence of CYP3A5 genetic differences in tacrolimus on quantitative interstitial fibrosis and long-term graft function in kidney transplant recipients. Int Immunopharmacol., 58, 57-63.
Narita, M., Kageyama, S., Okegawa, T., Kinoshita, H., Sato, F., Nakagawa, K., Habuchi, T., Hoshi, A., Matsubara, A., Yoshimura, K., Terachi, T., Mimata, H., Kawauchi, A. (2018) Urological laparoendoscopic single-site and reduced port surgery: A nationwide survey in Japan. Int J Urol., 25(3), 263-268.
Numakura, K., Fujiyama, N., Takahashi, M., Igarashi, R., Tsuruta, H., Maeno, A., Huang, M., Saito, M., Narita, S., Inoue, T., Satoh, S., Tsuchiya, N., Niioka, T., Miura, M., Habuchi, T. (2018) Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients. Oncotarget., 9(38), 25277-25284.
Oikawa, M., Hatakeyama, S., Yoneyma, T., Tobisawa, Y., Narita, T., Yamamoto, H., Hashimoto, Y., Koie, T., Narita, S., Sasaki, A., Tsuchiya, N., Habuchi, T., Takahashi, I., Nakaji, S., Ohyama, C. (2018) Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma. Eur Urol Focus., 4(3), 405-411.
Okubo, T., Mitsuzuka, K., Koie, T., Hoshi, S., Matsuo, S., Saito, S., Tsuchiya, N., Habuchi, T., Ohyama, C., Arai, Y; Michinoku Urological Cancer Study Group. (2018) Two years of bicalutamide monotherapy in patients with biochemical relapse after radical prostatectomy. Jpn J Clin Oncol., 48(6), 570-575.
Sato, H., Narita, S., Tsuchiya, N., Koizumi, A., Nara, T., Kanda, S., Numakura, K., Tsuruta, H., Maeno, A., Saito, M., Inoue, T., Satoh, S., Nomura, K., Habuchi, T. (2018) Impact of early changes in serum biomarkers following androgen deprivation therapy on clinical outcomes in metastatic hormone-sensitive prostate cancer. BMC Urol., 18(1), 32.
Yamamoto, H., Koie, T., Ookubo, T., Mitsuzuka, K., Narita, S., Inoue, T., Kawamura, S., Kato, T., Tochigi, T., Tsuchiya, N., Habuchi, T., Arai, Y., Ohyama, C. (2018) Can single positive core prostate cancer at biopsy be considered a low-risk disease? Int Urol Nephrol., 50(10), 1829-1833.